Cargando…
MCM2 - a promising marker for premalignant lesions of the lung: a cohort study
BACKGROUND: Because cells progressing to cancer must proliferate, marker proteins specific to proliferating cells may permit detection of premalignant lesions. Here we compared the sensitivities of a classic proliferation marker, Ki-67, with a new proliferation marker, MCM2, in 41 bronchial biopsy s...
Autores principales: | Tan, Dong-Feng, Huberman, Joel A, Hyland, Andrew, Loewen, Gregory M, Brooks, John SJ, Beck, Amy F, Todorov, Ivan T, Bepler, Gerold |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC35283/ https://www.ncbi.nlm.nih.gov/pubmed/11472637 http://dx.doi.org/10.1186/1471-2407-1-6 |
Ejemplares similares
-
Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
por: Yang, Jun, et al.
Publicado: (2006) -
Significance of DNA Replication Licensing Proteins (MCM2, MCM5 and CDC6), p16 and p63 as Markers of Premalignant Lesions of the Uterine Cervix: Its Usefulness to Predict Malignant Potential
por: Saritha, VN, et al.
Publicado: (2018) -
Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001) -
Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007) -
HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction
por: Ecker, Brett L., et al.
Publicado: (2016)